Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Clinical trial NCT06651281 · RECRUITING
Trial details
- NCT number
- NCT06651281
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2037-12-17
- Enrollment
- 1380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.